688238 logo

Obio Technology (Shanghai) XSSC:688238 Stock Report

Last Price

CN¥5.48

Market Cap

CN¥3.5b

7D

-5.4%

1Y

-49.3%

Updated

24 Nov, 2024

Data

Company Financials +

Obio Technology (Shanghai) Corp., Ltd.

XSSC:688238 Stock Report

Market Cap: CN¥3.5b

688238 Stock Overview

A biotechnology company, focuses on the development of gene therapy vectors in China. More details

688238 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth2/6
Past Performance0/6
Financial Health5/6
Dividends0/6

Obio Technology (Shanghai) Corp., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Obio Technology (Shanghai)
Historical stock prices
Current Share PriceCN¥5.48
52 Week HighCN¥11.43
52 Week LowCN¥3.86
Beta0.57
11 Month Change-1.08%
3 Month Change28.64%
1 Year Change-49.26%
33 Year Changen/a
5 Year Changen/a
Change since IPO-57.85%

Recent News & Updates

Recent updates

Shareholder Returns

688238CN Life SciencesCN Market
7D-5.4%-4.4%-2.1%
1Y-49.3%-32.3%2.8%

Return vs Industry: 688238 underperformed the CN Life Sciences industry which returned -32.3% over the past year.

Return vs Market: 688238 underperformed the CN Market which returned 2.8% over the past year.

Price Volatility

Is 688238's price volatile compared to industry and market?
688238 volatility
688238 Average Weekly Movement10.3%
Life Sciences Industry Average Movement10.6%
Market Average Movement8.4%
10% most volatile stocks in CN Market12.7%
10% least volatile stocks in CN Market5.7%

Stable Share Price: 688238 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 688238's weekly volatility (10%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2013722Guodong Jiawww.obiosh.com

Obio Technology (Shanghai) Corp., Ltd., a biotechnology company, focuses on the development of gene therapy vectors in China. The company provides gene function and gene therapy research, and other CRO services, such as drug target and drug efficacy research. It also offers CDMO services, such as process development and testing, IND-CMC pharmaceutical research, and clinical sample GMP production for the research and development of genetic drugs.

Obio Technology (Shanghai) Corp., Ltd. Fundamentals Summary

How do Obio Technology (Shanghai)'s earnings and revenue compare to its market cap?
688238 fundamental statistics
Market capCN¥3.55b
Earnings (TTM)-CN¥246.61m
Revenue (TTM)CN¥251.68m

14.1x

P/S Ratio

-14.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
688238 income statement (TTM)
RevenueCN¥251.68m
Cost of RevenueCN¥316.36m
Gross Profit-CN¥64.68m
Other ExpensesCN¥181.93m
Earnings-CN¥246.61m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.38
Gross Margin-25.70%
Net Profit Margin-97.98%
Debt/Equity Ratio11.5%

How did 688238 perform over the long term?

See historical performance and comparison